Abstract:Background: Erectile dysfunction (ED) is a debilitating medical condition in which current treatments are minimally effective in diabetic patients due to neuropathy of the cavernous nerve, a peripheral nerve that innervates the penis. Loss of innervation causes apoptosis of penile smooth muscle, remodeling of corpora cavernosa (penile erectile tissue) morphology, and ED. Aim: In this study, microarray and pathway analysis were used to obtain a global understanding of how signaling mechanisms are altered in diabetic patients and animal models as ED develops, in order to identify novel targets for disease management, and points of intervention for clinical therapy development. Methods and outcomes: Human corpora cavernosal tissue was obtained from diabetic (n = 4) and Peyronie's (control, n = 3) patients that were undergoing prosthesis implant to treat ED, and BB/WOR diabetic (n = 5) and resistant (n = 5) rats. RNA was extracted using TRIzol, DNase treated, and purified by Qiagen mini kit. Microarray was performed using the Human Gene 2.0 ST Array. (i) Alterations in patient and diabetic rat pathway signaling were examined using several analytical tools (ShinyGO, Metascape, WebGestalt, STRING) and databases, (ii) Strengths/weaknesses of the different pathway analysis tools were compared, and (iii) Comparison of human and rat (BB/WOR and Streptozotocin) pathway analysis was performed. Two technical replicates were performed. P value (FDR) < .15 was used as threshold for differential expression. FDR < 0.05 was considered significant. Results: Microarray identified 182 differentially expressed protein-coding genes. Pathway analysis revealed similar enrichments with different analytical tools. Down regulated pathways include development, tubular structure, sprouting, cell death, ischemia, angiogenesis, transcription, second messengers, and stem cell differentiation. ED patients, who have diabetes, incur significant loss of normal regulatory processes required for repair and replacement of injured corpora cavernosal tissue. Combined with loss of apoptotic regulatory mechanisms, this results in significant architectural remodeling of the corpora cavernosa, and loss of regenerative capacity in the penis. Clinical translation: This first report of microarray and pathway analysis in human corpora cavernosa, is critical for identification of novel pathways pertinent to ED and for validating animal models. Strengths and limitations: The analysis of tissue specific gene expression profiles provides a means of understanding drivers of disease and identifying novel pathways for clinical intervention. Conclusion: Penis from diabetic ED patients lacks capacity for maintenance of corpora cavernosal architecture and regeneration, which are critical points for intervention for therapy development. Searl T, Ohlander S, McVary KT, et al., Pathway Enrichment Analysis of Microarray Data Fom Human Penis of Diabetic and Peyronie's Patients, in Comparison With Diabetic Rat Erectile Dysfunction Models. J Sex Med 2022;19:37-53.

Screening and Identification of Critical Biomarkers in Erectile Dysfunction: Evidence from Bioinformatic Analysis

Identification and validation of new fatty acid metabolism–related mechanisms and biomarkers for erectile dysfunction

Identification of Key Genes and Pathways in Endometriosis by Integrated Expression Profiles Analysis.

Uncovering the genetic links of diabetic erectile dysfunction and chronic prostatitis/chronic pelvic pain syndrome

Screening and Identification of NOTCH1, CDKN2A, and NOS3 As Differentially Expressed Autophagy-Related Genes in Erectile Dysfunction.

Peer Review #1 of "screening and Identification of NOTCH1, CDKN2A, and NOS3 As Differentially Expressed Autophagy-Related Genes in Erectile Dysfunction (V0.1)"

Exploring potential genes and mechanisms linking erectile dysfunction and depression

Identification of key genes in type 2 diabetes-induced erectile dysfunction rats with stem cell therapy through high-throughput sequencing and bioinformatic analysis

Screening and identification of key biomarkers of depression using bioinformatics

Investigation of gene expression and genetic simultaneous control associated with erectile dysfunction and diabetes

Single-cell RNA sequencing reveals critical modulators of extracellular matrix of penile cavernous cells in erectile dysfunction

Pathway Enrichment Analysis of Microarray Data Fom Human Penis of Diabetic and Peyronie's Patients, in Comparison With Diabetic Rat Erectile Dysfunction Models

Identification of Oxidative Stress-Induced Gene Expression Profiles in Cavernosal Endothelial Cells.

Differentially Expressed Micrornas in the Corpus Cavernosum from a Murine Model with Type 2 Diabetes Mellitus-Associated Erectile Dysfunction.

Identification of Key microRNAs in Diabetes Mellitus Erectile Dysfunction Rats with Stem Cell Therapy by Bioinformatic Analysis of Deep Sequencing Data

Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis

Screening and Identification of Key Biomarkers in Hepatocellular Carcinoma: Evidence from Bioinformatic Analysis

The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer.

Identification of Potential Core Genes and Promising Compounds in STEMI Using Bioinformatics Analysis

Comparative Transcriptome Analyses of Geriatric Rats Associate Age-Related Erectile Dysfunction With a lncRNA-miRNA-mRNA Regulatory Network

Screening and identification of key genes for cervical cancer, ovarian cancer and endometrial cancer by combinational bioinformatic analysis